Transparency in quality of radiotherapy for breast cancer in the Netherlands: a national registration of radiotherapy-parameters ...

Abstract Background Radiotherapy (RT) is part of the curative treatment of approximately 70% of breast cancer (BC) patients. Wide practice variation has been reported in RT dose, fractionation and its treatment planning for BC. To decrease this practice variation, it is essential to first gain insight into the current variation in RT treatment between institutes. This paper describes the development of the NABON Breast Cancer Audit-Radiotherapy (NBCA-R), a structural nationwide registry of BC RT data of all BC patients treated with at least surgery and RT. Methods A working group consisting of... Mehr ...

Verfasser: Maliko, Nansi
Stam, Marcel R.
Boersma, Liesbeth J.
Vrancken Peeters, Marie-Jeanne T. F. D.
Wouters, Michel W. J. M.
KleinJan, Eline
Mulder, Maurice
Essers, Marion
Hurkmans, Coen W.
Bijker, Nina
Dokumenttyp: Datenquelle
Erscheinungsdatum: 2022
Verlag/Hrsg.: figshare
Schlagwörter: Medicine / Genetics / FOS: Biological sciences / Pharmacology / 39999 Chemical Sciences not elsewhere classified / FOS: Chemical sciences / 69999 Biological Sciences not elsewhere classified / 80699 Information Systems not elsewhere classified / FOS: Computer and information sciences / Developmental Biology / Cancer / Hematology / Plant Biology
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-29167566
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://dx.doi.org/10.6084/m9.figshare.c.5945289.v1

Abstract Background Radiotherapy (RT) is part of the curative treatment of approximately 70% of breast cancer (BC) patients. Wide practice variation has been reported in RT dose, fractionation and its treatment planning for BC. To decrease this practice variation, it is essential to first gain insight into the current variation in RT treatment between institutes. This paper describes the development of the NABON Breast Cancer Audit-Radiotherapy (NBCA-R), a structural nationwide registry of BC RT data of all BC patients treated with at least surgery and RT. Methods A working group consisting of representatives of the BC Platform of the Dutch Radiotherapy Society selected a set of dose volume parameters deemed to be surrogate outcome parameters, both for tumour control and toxicity. Two pilot studies were carried out in six RT institutes. In the first pilot study, data were manually entered into a secured web-based system. In the second pilot study, an automatic Digital Imaging and Communications in Medicine ...